Laura Tío1, Johanne Martel-Pelletier2, Jean-Pierre Pelletier2, Paul N Bishop3, Peter Roughley4, Aina Farran5, Pere Benito6, Jordi Monfort6. 1. Cellular Inflammation and Cartilage Research Group, IMIM (Hospital del Mar Research Institute), C/Dr. Aigüader 88, 08003 Barcelona, Spain. Electronic address: ltio@imim.es. 2. Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, Quebec, Canada. 3. Institute of Human Development, University of Manchester and Manchester Royal Eye Hospital and Centre for Advanced Discovery and Experimental Therapeutics, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom. 4. Department of Surgery, McGill University, Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada. 5. Cellular Inflammation and Cartilage Research Group, IMIM (Hospital del Mar Research Institute), C/Dr. Aigüader 88, 08003 Barcelona, Spain. 6. Cellular Inflammation and Cartilage Research Group, IMIM (Hospital del Mar Research Institute), C/Dr. Aigüader 88, 08003 Barcelona, Spain; Department of Rheumatology, Universitat Autònoma de Barcelona, Hospital del Mar, Barcelona, Spain.
Abstract
OBJECTIVE: Opticin is a class III member of the small leucine-rich repeat proteoglycan (SLRP) family, produced in articular joint tissues. In normal and osteoarthritic (OA) cartilage, opticin is degraded. This study aimed to assess whether human cartilage opticin is degraded by the main proteases involved in OA pathophysiology, and to determine the protease cleavage sites of this SLRP. METHODS: We analyzed the proteolytic activity of matrix metalloproteinases (MMPs)-1, -2, -3, -7, -8 and -9, and ADAMTS-4 and -5 on proteoglycan extracts from normal and moderately fibrillated OA human cartilage, and on recombinant human opticin. Opticin degradation was analyzed by Western blotting and cleavage sites were determined by sequence analysis. RESULTS: All eight proteases digested opticin from proteoglycan extracts from both normal and OA samples, as well as recombinant human opticin, MMP-2 and MMP-7 are the proteases that degrade recombinant human opticin most efficiently. The opticin cleavage site determined for these MMPs was between the glycosylation and leucine-rich repeat domains. MMP-7 had two additional digestion sites near the N-terminal end of opticin. CONCLUSION: Opticin is a substrate for several MMPs and aggrecanases involved during OA cartilage degradation, and seems to be a preferential substrate for MMP-7. The role of opticin in cartilage degeneration could be related to decreased levels of intact opticin, followed by its proteolytic degradation, which in turn may stimulate some of the modifications observed in the OA cartilage, such as neovascularisation and changes in the extracellular matrix.
OBJECTIVE: Opticin is a class III member of the small leucine-rich repeat proteoglycan (SLRP) family, produced in articular joint tissues. In normal and osteoarthritic (OA) cartilage, opticin is degraded. This study aimed to assess whether humancartilage opticin is degraded by the main proteases involved in OA pathophysiology, and to determine the protease cleavage sites of this SLRP. METHODS: We analyzed the proteolytic activity of matrix metalloproteinases (MMPs)-1, -2, -3, -7, -8 and -9, and ADAMTS-4 and -5 on proteoglycan extracts from normal and moderately fibrillated OA humancartilage, and on recombinant human opticin. Opticin degradation was analyzed by Western blotting and cleavage sites were determined by sequence analysis. RESULTS: All eight proteases digested opticin from proteoglycan extracts from both normal and OA samples, as well as recombinant human opticin, MMP-2 and MMP-7 are the proteases that degrade recombinant human opticin most efficiently. The opticin cleavage site determined for these MMPs was between the glycosylation and leucine-rich repeat domains. MMP-7 had two additional digestion sites near the N-terminal end of opticin. CONCLUSION: Opticin is a substrate for several MMPs and aggrecanases involved during OA cartilage degradation, and seems to be a preferential substrate for MMP-7. The role of opticin in cartilage degeneration could be related to decreased levels of intact opticin, followed by its proteolytic degradation, which in turn may stimulate some of the modifications observed in the OA cartilage, such as neovascularisation and changes in the extracellular matrix.
Authors: Douglas D Fraser; Gediminas Cepinskas; Eric K Patterson; Marat Slessarev; Claudio Martin; Mark Daley; Maitray A Patel; Michael R Miller; David B O'Gorman; Sean E Gill; Guillaume Pare; Ioannis Prassas; Eleftherios Diamandis Journal: Crit Care Explor Date: 2020-08-24
Authors: Lucie Válková; Jana Ševčíková; Monika Pávková Goldbergová; Adam Weiser; Antonín Dlouhý Journal: J Mater Sci Mater Med Date: 2018-08-30 Impact factor: 3.896
Authors: Andrew E Pouw; Mark A Greiner; Razek G Coussa; Chunhua Jiao; Ian C Han; Jessica M Skeie; John H Fingert; Robert F Mullins; Elliott H Sohn Journal: Cells Date: 2021-03-20 Impact factor: 7.666
Authors: Shermaine W Y Low; Thomas B Connor; Iris S Kassem; Deborah M Costakos; Shyam S Chaurasia Journal: Int J Mol Sci Date: 2021-07-07 Impact factor: 5.923